Non-alcoholic fatty liver disease (NAFLD) progression to non-alcoholic steatohepatitis (NASH) and NASH-related hepatocellular carcinoma (HCC) evolves following a differential activation of endoplasmic reticulum stress responses

被引：0

作者：

Finnemore, Alexander ^{[1
]}

Maria Herranz, Jose ^{[1
,2
]}

Barace, Sergio ^{[1
]}

Infante, Stefany ^{[1
,3
]}

Avila, Matias A. ^{[1
,4
]}

Garcia-Porrero, Guillermo ^{[5
]}

Arcelus, Sara ^{[1
]}

Santamaria, Eva ^{[1
]}

Argemi, Josepmaria ^{[1
,4
,5
]}

机构：

[1] Ctr Invest Med Aplicada CIMA, Hepatol Program, Pamplona, Spain

[2] Ctr invest biomed red CIBER EHD, Pamplona, Spain

[3] Univ Piura Lima campus, Miraflores, Peru

[4] Inst Invest Navarra IdisNA, Navarra, Spain

[5] Univ Navarra Clin, Liver Unit, Pamplona, Spain

来源：

JOURNAL OF HEPATOLOGY | 2022年 / 77卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

SAT064

引用

页码：S697 / S697

页数：1

共 50 条

[1] Non-alcoholic fatty liver disease (NAFLD). Non-alcoholic steatohepatitis - NASH
Keller, KM
MONATSSCHRIFT KINDERHEILKUNDE, 2004, 152 (08) : 864 - 869
[2] Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment
Bugianesi, E
Marzocchi, R
Villanova, N
Marchesini, G
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2004, 18 (06) : 1105 - 1116
[3] Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in HIV
Jürgen Kurt Rockstroh
Current HIV/AIDS Reports, 2017, 14 : 47 - 53
[4] Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in HIV
Rockstroh, Juergen Kurt
CURRENT HIV/AIDS REPORTS, 2017, 14 (02) : 47 - 53
[5] Recurrence of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Following Liver Transplantation for NASH Cirrhosis
Matsuoka, Lea
Slaughter, James
Campbell, Kathyrn
Kerr, Ashlie
Hamel, Stephanie
Garza, Carissa
Chotai, Pranit
Alexopoulos, Sophoclis
Scanga, Andrew
AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 15 - 15
[6] Non-alcoholic steatohepatitis (NASH)/non-alcoholic fatty liver disease (NAFLD) - A growing epidemic
South, K
GASTROENTEROLOGY NURSING, 2006, 29 (02) : 169 - 169
[7] Non-alcoholic Fatty Liver Disease (NAFLD) and non-alcoholic Steatohepatitis (NASH): Pathophysiology and Nutritional Aspects
Schattenberg, Joern M.
ERNAHRUNGS UMSCHAU, 2015, 62 (02): : M92 - M100
[8] Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course
Cortez-Pinto, H
Camilo, ME
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2004, 18 (06) : 1089 - 1104
[9] Linagliptin is an Effective Therapeutic for Non-alcoholic Fatty Liver Disease (NAFLD) and Non-alcoholic Steatohepatitis (NASH)
Klein, Thomas
Mark, Michael
DIABETES, 2012, 61 : A265 - A266
[10] Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
Miele, Luca
Forgione, Alessandra
Gasbarrini, Giovanni
Grieco, Antonio
TRANSLATIONAL RESEARCH, 2007, 149 (03) : 114 - 125

← 1 2 3 4 5 →